JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

Search

Globus Medical Inc (Class A)

Закрыт

СекторЗдравоохранение

94.46 -0.37

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

93.32

Макс.

95.36

Ключевые показатели

By Trading Economics

Доход

22M

141M

Продажи

57M

826M

P/E

Средняя по отрасли

24.699

60.328

Прибыль на акцию

1.28

Рентабельность продаж

17.013

Сотрудники

6,000

EBITDA

29M

244M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+17.79% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

7 мая 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

481M

13B

Предыдущая цена открытия

94.83

Предыдущая цена закрытия

94.46

Новостные настроения

By Acuity

50%

50%

178 / 348 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Globus Medical Inc (Class A) График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

24 апр. 2026 г., 00:00 UTC

Отчет

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24 апр. 2026 г., 00:00 UTC

Отчет

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23 апр. 2026 г., 23:47 UTC

Обсуждения рынка

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23 апр. 2026 г., 23:43 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

23 апр. 2026 г., 23:43 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

23 апр. 2026 г., 23:43 UTC

Обсуждения рынка

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23 апр. 2026 г., 23:13 UTC

Приобретения, слияния, поглощения

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23 апр. 2026 г., 22:33 UTC

Отчет

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23 апр. 2026 г., 22:17 UTC

Отчет

PLS Executed Offtake Agreement With Ronbay

23 апр. 2026 г., 22:17 UTC

Отчет

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23 апр. 2026 г., 22:16 UTC

Отчет

PLS Commences Commissioning of Midstream Demonstration Plant

23 апр. 2026 г., 22:15 UTC

Отчет

PLS Group Reaffirms FY26 Guidance for All Metrics

23 апр. 2026 г., 22:14 UTC

Отчет

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23 апр. 2026 г., 22:14 UTC

Отчет

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23 апр. 2026 г., 22:13 UTC

Отчет

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23 апр. 2026 г., 22:12 UTC

Отчет

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23 апр. 2026 г., 22:12 UTC

Отчет

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23 апр. 2026 г., 22:11 UTC

Отчет

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23 апр. 2026 г., 22:10 UTC

Отчет

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23 апр. 2026 г., 22:09 UTC

Отчет

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23 апр. 2026 г., 22:08 UTC

Отчет

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23 апр. 2026 г., 22:04 UTC

Отчет

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23 апр. 2026 г., 21:56 UTC

Обсуждения рынка
Отчет

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23 апр. 2026 г., 21:48 UTC

Приобретения, слияния, поглощения

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23 апр. 2026 г., 21:27 UTC

Отчет

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23 апр. 2026 г., 21:25 UTC

Отчет

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23 апр. 2026 г., 21:24 UTC

Отчет

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23 апр. 2026 г., 21:24 UTC

Отчет

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23 апр. 2026 г., 21:21 UTC

Отчет

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23 апр. 2026 г., 21:21 UTC

Отчет

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Сравнение c конкурентами

Изменение цены

Globus Medical Inc (Class A) Прогноз

Целевая цена

By TipRanks

17.79% рост

Прогноз на 12 месяцев

Средняя 111.9 USD  17.79%

Максимум 123 USD

Минимум 100 USD

Основано на мнении 11 аналитиков Wall Street, спрогнозировавших целевые цены для Globus Medical Inc (Class A) на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

11 ratings

10

Покупка

1

Удержание

0

Продажа

Техническая оценка

By Trading Central

72.18 / 73.07Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bearish Evidence

Долгосрочная

Weak Bearish Evidence

Настроения

By Acuity

178 / 348Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat